Moderately bullish activity in Moderna (MRNA), with shares up $1.95, or 7.5%, near $27.96. Options volume relatively light with 33k contracts traded and calls leading puts for a put/call ratio of 0.38, compared to a typical level near 0.83. Implied volatility (IV30) is higher by 1.2 points near 86.61, in the highest 10% of observations over the past year, suggesting an expected daily move of $1.53. Put-call skew steepened, indicating increased demand for downside protection.Looking ahead: Moderna (MRNA) will report earnings after the close on None.Option markets are pricing in a 50% probability of a move greater than 0.0% or $0.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Early notable gainers among liquid option names on October 20th
- VOO ETF News, 10/20/2025
- Hold Rating on Moderna’s mRNA-4359: Promising Early Data but Awaiting Further Validation
- Moderna announces data on flu, pandemic flu candidates at IDWeek 2025
- Moderna ‘checking another mark’ in oncology franchise, says Wolfe Research